| RS2482893792 |
SKIC2
|
Health Risk |
Pathogenic |
Trichohepatoenteric syndrome 2, Trichohepatoenteric syndrome 2 |
| RS2482901097 |
SKIC2
|
Health Risk |
Likely pathogenic |
— |
| RS2482907794 |
SKIC2
|
Health Risk |
Likely pathogenic |
— |
| RS2482907806 |
SKIC2
|
Health Risk |
Likely pathogenic |
— |
| RS2482913862 |
SKIC2
|
Health Risk |
Pathogenic |
SKIC2-related disorder, Trichohepatoenteric syndrome |
| RS2482914494 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2482921524 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2482923446 |
SKIC2
|
Health Risk |
Likely pathogenic |
— |
| RS2482925700 |
RARS2
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2482926092 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2482927479 |
BCKDHB
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease type 1A, Maple syrup urine disease type 1A |
| RS2482927788 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2482941580 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2482941811 |
SKIC2
|
Health Risk |
Likely pathogenic |
— |
| RS2482941903 |
SKIC2
|
Health Risk |
Likely pathogenic |
— |
| RS2482946278 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2482948092 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2482951128 |
LTBP1
|
Health Risk |
Likely pathogenic |
— |
| RS2482951342 |
SKIC2
|
Health Risk |
Likely pathogenic |
— |
| RS2482962077 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2482962245 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2482963880 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2482964196 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2482974419 |
SKIC2
|
Health Risk |
Likely pathogenic |
— |
| RS2482977604 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2482978171 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2482980547 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2482986290 |
SKIC2
|
Health Risk |
Likely pathogenic |
— |
| RS2482987023 |
GABBR1
|
Health Risk |
Likely pathogenic |
Delayed speech and language development, Intellectual disability |
| RS2482987424 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2482991939 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2482992258 |
SKIC2
|
Health Risk |
Likely pathogenic |
— |
| RS2482996768 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2482998760 |
SKIC2
|
Health Risk |
Likely pathogenic |
SKIC2-related disorder, SKIC2-related disorder |
| RS2482998785 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2483001580 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2483002301 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2483002672 |
SKIC2
|
Health Risk |
Likely pathogenic |
Trichohepatoenteric syndrome, Trichohepatoenteric syndrome |
| RS2483004287 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2483004524 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2483014149 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2483015903 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2483018539 |
TAP2
|
Health Risk |
Pathogenic |
MHC class I deficiency, MHC class I deficiency |
| RS2483030686 |
SMOC2
|
Health Risk |
Pathogenic |
— |
| RS2483031868 |
TAP2
|
Health Risk |
Pathogenic |
MHC class I deficiency, MHC class I deficiency |
| RS2483041289 |
GRIK2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with impaired language and ataxia and with or without seizures, Neurodevelopmental disorder with impaired language and ataxia and with or without seizures |
| RS2483045582 |
TAP2
|
Health Risk |
Pathogenic |
MHC class I deficiency, MHC class I deficiency |
| RS2483057361 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2483057578 |
AHI1
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2483060451 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontoneocerebellar hypoplasia, Pontoneocerebellar hypoplasia |
| RS2483063381 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2483071538 |
HACE1
|
Health Risk |
Likely pathogenic |
— |
| RS2483080517 |
RARS2
|
Health Risk |
Pathogenic |
— |
| RS2483083592 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2483085708 |
RARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2483086717 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2483087076 |
PSMB8
|
Health Risk |
Pathogenic |
Proteosome-associated autoinflammatory syndrome, Proteosome-associated autoinflammatory syndrome |
| RS2483089065 |
SLC37A4
|
Health Risk |
Likely pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS2483090982 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2483093313 |
RARS2
|
Health Risk |
Pathogenic |
— |
| RS2483095040 |
PSMB8
|
Health Risk |
Likely pathogenic |
Proteosome-associated autoinflammatory syndrome, Proteosome-associated autoinflammatory syndrome |
| RS2483096056 |
PSMB8
|
Health Risk |
Pathogenic |
Proteosome-associated autoinflammatory syndrome, Proteosome-associated autoinflammatory syndrome |
| RS2483121020 |
TAP1
|
Health Risk |
Pathogenic |
MHC class I deficiency, MHC class I deficiency |
| RS2483139594 |
TAP1
|
Health Risk |
Pathogenic |
MHC class I deficiency, MHC class I deficiency |
| RS2483139752 |
TAP1
|
Health Risk |
Pathogenic |
MHC class I deficiency, MHC class I deficiency |
| RS2483142817 |
TAP1
|
Health Risk |
Pathogenic |
MHC class I deficiency, MHC class I deficiency |
| RS2483143302 |
HACE1
|
Health Risk |
Likely pathogenic |
Spastic paraplegia-severe developmental delay-epilepsy syndrome, Spastic paraplegia-severe developmental delay-epilepsy syndrome |
| RS2483155390 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2483156696 |
RARS2
|
Health Risk |
Pathogenic |
— |
| RS2483160388 |
RARS2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2483162654 |
TAP1
|
Health Risk |
Pathogenic |
MHC class I deficiency, MHC class I deficiency |
| RS2483164110 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2483164755 |
PRKN
|
Health Risk |
Pathogenic |
— |
| RS2483164857 |
PRKN
|
Health Risk |
Pathogenic |
— |
| RS2483165715 |
RARS2
|
Health Risk |
Likely pathogenic |
— |
| RS2483168330 |
TAP1
|
Health Risk |
Pathogenic |
MHC class I deficiency, MHC class I deficiency |
| RS2483175972 |
COL9A1
|
Health Risk |
Pathogenic |
— |
| RS2483176844 |
COL9A1
|
Health Risk |
Likely pathogenic |
— |
| RS2483177125 |
TAP1
|
Health Risk |
Pathogenic |
MHC class I deficiency, MHC class I deficiency |
| RS2483177661 |
ADGRG6
|
Health Risk |
Likely pathogenic |
Lethal congenital contracture syndrome 9, Lethal congenital contracture syndrome 9 |
| RS2483185391 |
TAP1
|
Health Risk |
Pathogenic |
MHC class I deficiency, MHC class I deficiency |
| RS2483189043 |
RARS2
|
Health Risk |
Likely pathogenic |
— |
| RS2483190231 |
RARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2483190241 |
TAP1
|
Health Risk |
Pathogenic |
MHC class I deficiency, MHC class I deficiency |
| RS2483190622 |
COL9A1
|
Health Risk |
Likely pathogenic |
— |
| RS2483206286 |
PNLDC1
|
Health Risk |
Likely pathogenic |
Spermatogenic failure 57, Spermatogenic failure 57 |
| RS2483216049 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2483216603 |
RNASET2
|
Health Risk |
Pathogenic |
Cystic leukoencephalopathy without megalencephaly, Cystic leukoencephalopathy without megalencephaly |
| RS2483230018 |
LATS1
|
Health Risk |
Pathogenic |
Myoepithelial tumor, Myoepithelial tumor |
| RS2483237716 |
COL9A1
|
Health Risk |
Likely pathogenic |
— |
| RS2483242918 |
COL9A1
|
Health Risk |
Likely pathogenic |
— |
| RS2483243726 |
PRKAR1B
|
Health Risk |
Likely pathogenic |
Marbach-Schaaf neurodevelopmental syndrome, Marbach-Schaaf neurodevelopmental syndrome |
| RS2483248331 |
COL9A1
|
Health Risk |
Pathogenic |
— |
| RS2483253242 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2483256407 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2483264736 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2483267737 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2483267924 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2483268122 |
AHI1
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2483298866 |
GABBR1
|
Health Risk |
Likely pathogenic |
Atypical behavior, Global developmental delay |